
Merck & Co has followed through with an earlier threat to close down its manufacturing operations at Kenilworth, New Jersey. …

Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors. MacDonald is the former executive …
Kenneth Frazier is to be the next chief executive of Merck & Co from 1 January 2011 following his election …
A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …
Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …
The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …
Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …
A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …
The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …


